MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases.
The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology.
The company was founded in 2000 and is headquartered in Rockville, Maryland.
Current Team (9)Update
Senior Vice President, Research
Vice President, Controller and Treasurer
Vice President, Chief Financial Officer
President & Chief Executive Officer and Board Member
Observer of Boards
Vice President, Development
Senior Vice President, Product Development and Regulatory Affairs
Vice President, Clinical Oncology Research
Past Team (5)Update
Funding Rounds (2) - $57MUpdate
Board Members and Advisors (10)Update
Early-Stage Biotech Investment
Ventures West is one of Canada's largest privately owned venture capital companies. In...
Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since...
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
Healthcare Venture Capital
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
1500 East Gude Drive
Rockville, MD 20850
LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for...
- 11/10/13 -nasdaq.com